ADMA
Adma Biologics Inc
2 super-investors hold ADMA worth a combined $66M. The largest position: Stanley Druckenmiller at 0.5% of their portfolio. This quarter the cohort logged 1 buy and 0 sells on the name. Cohort Conviction Score: 44 — ranked #80 of 724 scored stocks.
Why super-investors own ADMA
Greenblatt holds the larger dollar position at $52M, though it registers as a rounding error in his diversified portfolio; Druckenmiller's $14M stake at 0.5% of portfolio represents his higher-conviction read on the name. The more notable data point this quarter is that Druckenmiller added to his position in 2026Q1, the only cohort activity recorded. Broader interest remains thin — the owner count has held at just one or two funds for at least eight consecutive quarters with no new entrants this period — suggesting ADMA is a specialist or opportunistic holding rather than an emerging consensus idea among the super-investor cohort.
AI-synthesized from 13F filings. Not investment advice.
Cohort owners over time
2025Q4 → 2026Q1How many of the cohort members held this stock each quarter.
Owners (2) · click any column to sort
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | Joel Greenblatt | <0.1% | 26q | $52M | 5,810,642 |
| 2 | Stanley Druckenmiller | 0.5% | 2q | $14M | 1,545,610 |
Owners of ADMA also hold
Recent activity (1)
| Manager | Move | % Port. | Δ Shares | Value | Filed |
|---|---|---|---|---|---|
| Stanley Druckenmiller | ADD | 0.5% | +513% | $14M | May 15, 2026 |
Long US equity 13F-HR filings only. CUSIP 000899104. Not investment advice.